Italian life sciences investor Panakès Partners has hired Rob Woodman as partner to lead the firm’s newly created biotech investment team.
The hiring followed the firm’s €150m first close for its second life sciences fund in July which enabled it to extend investments into biotech sector.
Panakès said Woodman has global experience in biotech gained at both institutional and corporate venture firms and from start-up through to growth investments. He was senior partner at Takeda Ventures and head of Takeda’s R&D internal incubation since 2018. Previously, Woodman was a partner in the healthcare investment team at Touchstone Innovations in London.
His investments in the sector include Inivata, Enterprise Therapeutics, Emendo and BioMx.
Fabrizio Landi, president of Panakès said, “We are delighted to have Rob join the team at this exciting moment for Panakès – Rob brings a wealth of experience in the biotech field, complementing our existing team’s capabilities in medtech and diagnostics. Led by Rob, the Panakès biotech team will support leading biotech entrepreneurs and founders to create companies able to transform patient care.”
Panakès said it will invest in biotech companies at the forefront of global innovation with the potential to transform patient care. It closed its debut medtech fund on €100m target in 2016.
Copyright © 2021 AltAssets